STAGE III RENAL PELVIS AND URETER CANCER AJCC V7

Clinical trials for STAGE III RENAL PELVIS AND URETER CANCER AJCC V7 explained in plain language.

Never miss a new study

Get alerted when new STAGE III RENAL PELVIS AND URETER CANCER AJCC V7 trials appear

Sign up with your email to follow new studies for STAGE III RENAL PELVIS AND URETER CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial tests Immune-Boosting drug to stop aggressive bladder cancer from coming back

Disease control Ongoing

This large study is testing whether a drug called pembrolizumab can help prevent cancer from returning in people who have had surgery for muscle-invasive bladder or upper urinary tract cancer. After surgery, participants are randomly assigned to either receive the drug (which hel…

Matched conditions: STAGE III RENAL PELVIS AND URETER CANCER AJCC V7

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

STAGE III RENAL PELVIS AND URETER CANCER AJCC V7

Get alerted when new STAGE III RENAL PELVIS AND URETER CANCER AJCC V7 trials appear

Major trial tests Immune-Boosting drug to stop aggressive bladder cancer from coming back